Cyclobenzaprine hydrochloride

็›้…ธ็Žฏ่‹ฏๆ‰Žๆž—

Report date: 2026/02/13 20:01:31
NME

Base Information

Drug NameCyclobenzaprine hydrochloride
Drug Alias Name็Žฏ่‹ฏๆ‰Žๆž—็›้…ธ็›Cyclobenzaprinum hydrochlorideCyclobenzaprine HCL็›้…ธ่ƒบ่‹ฏ็Žฏๅบš็ƒฏ็›้…ธๆข่‹ฏๆ‰Žๆž— +[16]ย 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonistsAdrenergic receptors alpha-2 antagonists
TargetsSerotonin 2a (5-HT2a) receptorHistamine H1 receptorAdrenergic receptors alpha-2
Therapy Area/IndicationsLow Back PainPelvic Floor DisordersMuscle Spasticity +[4]ย 
Global Approved IndicationsMuscle Spasticity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1977/08/26
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesTonix Pharmaceuticals Holding CorpUniversity Of MichiganShandong Bestcomm Pharmaceutical Company Ltd
Inactive CompaniesJanssen Research & Development Llc
Active IndicationsLow Back PainPelvic Floor DisordersFibromyalgia
Inactive IndicationsMuscle Spasticity

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG